Meditoxin
Meditoxin is a pharmaceutical drug with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
0
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
9 of 9 finished
0.0%
0 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines
Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis
MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy
MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity
Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder
Clinical Trials (9)
Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines
Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis
MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy
MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity
Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder
Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers
Meditoxin® Treatment in Patients With Cervical Dystonia
Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers
Efficacy and Safety of Meditoxin® Injection for Cervical Dystonia in Adults With Cerebral Palsy
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9